An experimental antifibrotic compound can dramatically alter how cells release the microscopic packages they use to communicate, according to new research from the University of Surrey. Researchers found that the compound, SD-208, which reduces scar tissue in organs, substantially reduced the release of extracellular vesicles, microscopic packages that cells use to carry proteins and other biological signals to neighboring and distant cells.
❓ Unknown
Experimental Antifibrotic Drug SD-208 Shows Potential to Alter Cell Communication
Just now
October 1, 2026
1 min read
📰 Phys.org
📋 Key Takeaway
Research from the University of Surrey reveals that the experimental antifibrotic drug SD-208 can significantly alter cell communication by reducing the release of extracellular vesicles. This finding has potential implications for medical treatments related to fibrosis. While not directly related to Iranian politics, advancements in medical research could impact healthcare developments in Iran.
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
15 min ago •
Tracking Marine Mammals in the Mediterranean: Fin Whales and Sperm Whales
15 min ago •
Two Charged in Scheme to Sell Counterfeit Ozempic from China
15 min ago •
New Method Enhances Antibody Production in Human Blood Cells
18 min ago •
Iran and Russia Enhance Cooperation on Information Security and AI
24 min ago •